BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34528777)

  • 1. Determination of the frequency of hyperprolactinemia-related etiologies and the etiology-specific mean prolactin levels.
    Korkmaz FN; Gökçay Canpolat A; Şahin M; Çorapçioğlu D
    Minerva Endocrinol (Torino); 2021 Sep; ():. PubMed ID: 34528777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
    Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
    Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.
    Davoudi Z; Araghi F; Vahedi M; Mokhtari N; Gheisari M
    Acta Biomed; 2021 Nov; 92(5):e2021291. PubMed ID: 34738596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
    Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
    Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin secretion in polycystic ovary syndrome (PCOS).
    Szosland K; Pawlowicz P; Lewiński A
    Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
    Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
    J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
    Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
    J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
    Khorassanizadeh R; Sundaresh V; Levine SN
    World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological diagnosis of hyperprolactinemia.
    Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study.
    Dehghan E; Namiranian N; Ghadiri-Anari A; Kazem Razavi Ratki S; Azizi R
    Int J Reprod Biomed; 2021 Dec; 19(12):1085-1090. PubMed ID: 35098010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome and prolactinoma association.
    Yavasoglu I; Kucuk M; Coskun A; Guney E; Kadikoylu G; Bolaman Z
    Intern Med; 2009; 48(8):611-3. PubMed ID: 19367058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.
    Vilar L; Freitas MC; Naves LA; Casulari LA; Azevedo M; Montenegro R; Barros AI; Faria M; Nascimento GC; Lima JG; Nóbrega LH; Cruz TP; Mota A; Ramos A; Violante A; Lamounier Filho A; Gadelha MR; Czepielewski MA; Glezer A; Bronstein MD
    J Endocrinol Invest; 2008 May; 31(5):436-44. PubMed ID: 18560262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.
    Vilar L; Vilar CF; Lyra R; Freitas MDC
    Neuroendocrinology; 2019; 109(1):7-19. PubMed ID: 30889571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinemia: a new cause of hyperprolactinemia.
    Hattori N
    J Pharmacol Sci; 2003 Jul; 92(3):171-7. PubMed ID: 12890882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCOS and Hyperprolactinemia: what do we know in 2019?
    Delcour C; Robin G; Young J; Dewailly D
    Clin Med Insights Reprod Health; 2019; 13():1179558119871921. PubMed ID: 31523136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia.
    Bronstein MD; Knoepfelmacher M; Liberman B; Marino R; Germek OA; Schally AV
    Horm Metab Res; 1987 Jun; 19(6):271-4. PubMed ID: 2887502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.